Bleeding disorders:
Indications for: NITROPRESS
To produce controlled hypotension to reduce surgical bleeding.
Adults and Children:
Use infusion pump only. Monitor BP closely. Initially 0.3microgram/kg/min; may increase infusion rate every few minutes until desired effect; max 10microgram/kg/min and no more than 10 minutes. Titrate infusion rate (see literature).
NITROPRESS Contraindications:
Compensatory hypertension due to aortic coarctation or arteriovenous shunting. Inadequate cerebral circulation or moribund patients requiring emergency surgery. Congenital (Lebers) optic atrophy. Tobacco amblyopia. Acute CHF associated with reduced peripheral vascular resistance.
Boxed Warning:
Not suitable for direct injection. Excessive hypotension. Cyanide toxicity.
NITROPRESS Warnings/Precautions:
Use only when available equipment and personnel allow BP to be continuously monitored. Cyanide toxicity possible (esp. at infusion rates >2micrograms/kg/min); monitor acid-base disturbances and venous oxygen concentration. Elevated intracranial pressure. Correct pre-existing anemia and hypovolemia, esp. during anesthesia. Poor surgical risk. Hepatic impairment. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
NITROPRESS Classification:
Vasodilator.
NITROPRESS Interactions:
Hypotensive effect potentiated by ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
Adverse Reactions:
Excessive hypotension, cyanide toxicity, methemoglobinemia, abdominal pain, apprehension, diaphoresis, dizziness, headache, muscle twitch, nausea, palpitations, restlessness, rash, hypothyroidism, ileus, flushing, infusion site reactions.
How Supplied:
Single-dose vials (2mL)—100
CHF and arrhythmias:
Indications for: NITROPRESS
Acute CHF.
Adults and Children:
Use infusion pump only. Monitor BP closely. Initially 0.3microgram/kg/min; may increase infusion rate every few minutes until desired effect; max 10microgram/kg/min and no more than 10 minutes. Titrate infusion rate (see literature).
NITROPRESS Contraindications:
Compensatory hypertension due to aortic coarctation or arteriovenous shunting. Inadequate cerebral circulation or moribund patients requiring emergency surgery. Congenital (Lebers) optic atrophy. Tobacco amblyopia. Acute CHF associated with reduced peripheral vascular resistance.
Boxed Warning:
Not suitable for direct injection. Excessive hypotension. Cyanide toxicity.
NITROPRESS Warnings/Precautions:
Use only when available equipment and personnel allow BP to be continuously monitored. Cyanide toxicity possible (esp. at infusion rates >2micrograms/kg/min); monitor acid-base disturbances and venous oxygen concentration. Elevated intracranial pressure. Correct pre-existing anemia and hypovolemia, esp. during anesthesia. Poor surgical risk. Hepatic impairment. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
NITROPRESS Classification:
Vasodilator.
NITROPRESS Interactions:
Hypotensive effect potentiated by ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
Adverse Reactions:
Excessive hypotension, cyanide toxicity, methemoglobinemia, abdominal pain, apprehension, diaphoresis, dizziness, headache, muscle twitch, nausea, palpitations, restlessness, rash, hypothyroidism, ileus, flushing, infusion site reactions.
How Supplied:
Single-dose vials (2mL)—100
Hypertension:
Indications for: NITROPRESS
Immediate reduction of blood pressure during hypertensive crises.
Adults and Children:
Use infusion pump only. Monitor BP closely. Initially 0.3microgram/kg/min; may increase infusion rate every few minutes until desired effect; max 10microgram/kg/min and no more than 10 minutes. Titrate infusion rate (see literature).
NITROPRESS Contraindications:
Compensatory hypertension due to aortic coarctation or arteriovenous shunting. Inadequate cerebral circulation or moribund patients requiring emergency surgery. Congenital (Lebers) optic atrophy. Tobacco amblyopia. Acute CHF associated with reduced peripheral vascular resistance.
Boxed Warning:
Not suitable for direct injection. Excessive hypotension. Cyanide toxicity.
NITROPRESS Warnings/Precautions:
Use only when available equipment and personnel allow BP to be continuously monitored. Cyanide toxicity possible (esp. at infusion rates >2micrograms/kg/min); monitor acid-base disturbances and venous oxygen concentration. Elevated intracranial pressure. Correct pre-existing anemia and hypovolemia, esp. during anesthesia. Poor surgical risk. Hepatic impairment. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
NITROPRESS Classification:
Vasodilator.
NITROPRESS Interactions:
Hypotensive effect potentiated by ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
Adverse Reactions:
Excessive hypotension, cyanide toxicity, methemoglobinemia, abdominal pain, apprehension, diaphoresis, dizziness, headache, muscle twitch, nausea, palpitations, restlessness, rash, hypothyroidism, ileus, flushing, infusion site reactions.
How Supplied:
Single-dose vials (2mL)—100
